Glanis Life Sciences Private Limited

Glanis Life Sciences Private Limited - pharma in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U24232TG2010PTC068681 Incorporated 31 May 2010 ROC Hyderabad HQ Hyderabad, Telangana, India
Struck Off Private Limited Company pharma
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
16 yrs
Est. 2010
Directors on board
3
As per MCA filings
Last financials
Mar 2020
Balance sheet date
Last AGM
31 Dec 2020
Annual general meeting
Company status
Struck Off
MCA master data
Registrar
Hyderabad
ROC office

About Glanis Life Sciences Private Limited

Data last updated:

Glanis Life Sciences Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 May 2010.

The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2010PTC068681.

The company had an authorised share capital of ₹5 Cr and a paid-up capital of ₹1 Lakh. It was formerly known as Janani Labs Private Limited. It was led by directors including Sri Lakshmi Kondru and Sridhar Vootla.

Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Plot No. 406A H. No. 622 Road No. 18 Jubilee Hills, Hyderabad, Telangana, India – 500033.

Company details

CIN U24232TG2010PTC068681
Registration Number 068681
Incorporation Date 31 May 2010
ROC Hyderabad
Listing Status Unlisted
Company Status Struck Off
Compliance Status Active Compliant

CIN history

Glanis Life Sciences has one previous CIN (Corporate Identification Number): U24232AP2010PTC068681. The current CIN is U24232TG2010PTC068681, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TG2010PTC068681Current
U24232AP2010PTC068681Previous

Contact details

Glanis Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Plot No. 406A H. No. 622 Road No. 18 Jubilee Hills, Hyderabad, Telangana, India – 500033
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Glanis Life Sciences Private Limited, buy the company report.

Comprehensive company report
Glanis Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Glanis Life Sciences Private Limited

FY 2020 filings available

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Glanis Life Sciences Private Limited, buy the company report.

Board of directors of Glanis Life Sciences Private Limited

Glanis Life Sciences has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Sri Lakshmi KondruDirector28 Sep 201214 Years 1 MonthsAs last reported
Sridhar VootlaDirector16 Jan 201313 Years 10 MonthsAs last reported
Kudaravalli SridharDirector16 Jan 201313 Years 10 MonthsAs last reported

Auditor

Glanis Life Sciences Private Limited is audited by RAMASAMY KOTESWARA RAO & CO LLP for the financial year 2018.

Auditor firmFinancial yearFirm registration number
RAMASAMY KOTESWARA RAO & CO LLPFY 2018010396S

Shareholding

The shareholding of Glanis Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2018FY 2017FY 2016FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Glanis Life Sciences Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Glanis Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Glanis Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Glanis Life Sciences Private Limited has 10 board changes on record since 2012: 3 appointments and 7 cessations. The latest: Kudaravalli Sridhar ceased to be Additional Director on 30 Sep 2013.

AGM
Glanis Life Sciences Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Filing
Glanis Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.
Ceased
Kudaravalli Sridhar ceased to be Additional Director.
Ceased
Sri Lakshmi Kondru ceased to be Additional Director.
Ceased
Sridhar Vootla ceased to be Additional Director.
Ceased
Krishna Muttamsetty Rao ceased to be Additional Director.
Ceased
Pinisetty Surya Srinivas ceased to be Director.
Ceased
Vemuri Sambasiva Rao ceased to be Director.
Ceased
Vijayanirmala Muttamsetty ceased to be Additional Director.
Appointed
Kudaravalli Sridhar was appointed as Director.
Appointed
Sridhar Vootla was appointed as Director.
Appointed
Sri Lakshmi Kondru was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Glanis Life Sciences has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Glanis Life Sciences was a private limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 31 May 2010 and is registered under CIN U24232TG2010PTC068681. The company has been struck off by the Registrar of Companies and is no longer operational.

Glanis Life Sciences had 3 directors:

The CIN (Corporate Identification Number) of Glanis Life Sciences is U24232TG2010PTC068681. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Glanis Life Sciences is at Plot No. 406A H. No. 622 Road No. 18 Jubilee Hills, Hyderabad, Telangana, India – 500033.

Glanis Life Sciences was incorporated on 31 May 2010. It is registered with the Registrar of Companies, Hyderabad.

The latest financial statements of Glanis Life Sciences on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.

Glanis Life Sciences operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.

Kudaravalli Sridhar ceased to be Additional Director on 30 Sep 2013. Sri Lakshmi Kondru ceased to be Additional Director on 30 Sep 2013. Sridhar Vootla ceased to be Additional Director on 30 Sep 2013. Glanis Life Sciences has 10 board changes on record in total.

The compliance status of Glanis Life Sciences is compliant as of 30 August 2026.